🧠AI AnalysisFDA Approves Roche's New Breast Cancer Treatment Wilserdly
The Food and Drug Administration has cleared Roche's new oral therapy Wilserdly for specific advanced breast cancer patients, marking an important regulatory milestone fo…
🧠AI AnalysisThe Food and Drug Administration has cleared Roche's new oral therapy Wilserdly for specific advanced breast cancer patients, marking an important regulatory milestone fo…
🧠AI AnalysisFederal regulators have turned down an application for ivonescimab, an experimental lung cancer therapy invented in China and licensed by a U.S. firm, citing insufficient…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.